#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Non-small cell lung cancer recurrent Breast cancer Aplastic anaemia T-cell type acute leukaemia Peripheral primitive neuroectodermal tumour of soft tissue Hereditary ataxia Cutaneous lupus erythematosus Glomerulonephritis membranoproliferative Gastrointestinal disorder Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Arrhythmia Brain abscess Malignant peritoneal neoplasm Parkinson's disease Autoimmune hepatitis More trials…
Learn about Rare Diseases

Gastrointestinal stromal tumour – Life with Disease Rhabdomyosarcoma – Treatment Antisynthetase syndrome – Trials in Disease Turner’s syndrome – Life with Disease SAPHO syndrome – Life with Disease Leiomyosarcoma – Basic Information Optic glioma – Life with Disease Leiomyosarcoma recurrent – Diagnostics Antisynthetase syndrome Krabbe’s disease – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Clozapine Ovolecithin Retifanlimab Tetracycline Hydrochloride Dcc-3116 Cl-Ad-Msc-002 L-Lysine Acetate Oditrasertib Glatiramer Acetate Cilgavimab Romiplostim Liraglutide Soya-Bean Oil Refined Balcinrenone Istradefylline Glasdegib VIPOGLANSTAT ABY-271 Riluzole Avacincaptad Pegol More therapies…

Learn about Your Condition

Breast proliferative changes Diffuse large B-cell lymphoma Pharyngeal cancer stage III Ectopic pregnancy Gouty arthritis Uterine leiomyosarcoma Bladder cancer stage II Urinary incontinence Injection site pain Endometrial cancer stage IV Agitation Rectal cancer Erythema multiforme Hairy cell leukaemia Paraesthesia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Colon cancer metastatic

Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Colon cancer metastatic
Investigated Drugs:
Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Colon cancer metastatic
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Colon cancer metastatic

Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies